December 14, 2012 at 14:00 PM EST
Markets Down As Consumer Prices Slip
The markets traded lower during the midday with the Dow losing 5 points to 13,165 as November consumer prices slipped 0.3%. Nasdaq fell 14 points to 2977.
On the upside
Bargain hunters lifted shares of Rigel Pharmaceuticals (Nasdaq: RIGL), whose stock price fell yesterday on disappointing drug trial results.
A European Union advisory panel recommended approval for Alexza Pharmaceuticals' (Nasdaq: ALXA) agitation treatment Adasuve.
Shares of AK Steel Holding (NYSE: AKS) and U. S. Steel (NYSE: X) rose on Fitch Ratings' expectation for steel demand to continue growing slowly in 2013.
On the downside
The Food and Drug Administration granted early approval to Ariad Pharmaceuticals' (Nasdaq: ARIA) chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia treatment Iclusig but the stock price dropped. Jefferies analyst Peter Misek said that Apple (Nasdaq: AAPL) cut orders to component suppliers Cirrus Logic (NYSE: CRUS) and Skyworks Solutions (Nasdaq: SWKS).
Schlumberger (NYSE: SLB) warned that a slowdown in drilling will negatively impact its fourth quarter earnings.
In the broad market, declining issues barely edged out advancers by a slim margin on the NYSE while advancers outpaced decliners by 10 to 9 on Nasdaq. The broader S&P 500 index slipped 2 points to 1416.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here